Define range intervals using parentheses.
E.g. C7H(10-14)O(0-4)

to
±
(example: 123 ± 1)

to
±

to
±
 

to
±
 
Search Hits Limit:
Single/Multi-component
Isotopically Labeled
Additional Filters

Found 76 results

Search term: MF = 'C_{30}H_{29}ClN_{2}O_{7}'
1234
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
3518246

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C30H29ClN2O7/c1-16-27(30(35)40-20-5-3-2-4-6-20)28(21-13-25-26(39-15-38-25)14-23(21)33(36)37)29-22(32-16)11-18(12-24(29)34)17-7-9-19(31)10-8-17/h7-10,13-14,18,20,28,32H,2-6,11-12,15H2,1H3
C30H29ClN2O7565.013459999999211600
4707991

Double-bond stereo
InChI=1/C30H29ClN2O7/c1-4-13-39-24-12-8-21(16-27(24)38-3)17-33-29(35)23(28(34)32-30(33)36)14-20-7-11-25(26(15-20)37-2)40-18-19-5-9-22(31)10-6-19/h5-12,14-16H,4,13,17-18H2,1-3H3,(H,32,34,36)/b23-14+
C30H29ClN2O7565.0135131100
2614584

Double-bond stereo
InChI=1/C30H29ClN2O7/c1-4-13-39-24-12-8-21(16-27(24)38-3)17-33-29(35)23(28(34)32-30(33)36)14-20-7-11-25(26(15-20)37-2)40-18-19-5-9-22(31)10-6-19/h5-12,14-16H,4,13,17-18H2,1-3H3,(H,32,34,36)
C30H29ClN2O7565.01355200
2979232

0 of 5 defined stereocentres - 0/5 defined
InChI=1/C30H29ClN2O7/c1-16-12-13-19(14-21(16)31)33-27(35)23-24(28(33)36)30(17(2)34,29(37)38)32-25(23)20-10-7-11-22(39-3)26(20)40-15-18-8-5-4-6-9-18/h4-14,17,23-25,32,34H,15H2,1-3H3,(H,37,38)
C30H29ClN2O7565.0134599999992100
4175316

0 of 4 defined stereocentres - 0/4 defined
InChI=1/C30H29ClN2O7/c1-15-5-8-18(13-21(15)31)33-27(35)23-24(28(33)36)30(29(37)38,14-17-6-9-19(34)10-7-17)32-25(23)20-11-12-22(39-3)16(2)26(20)40-4/h5-13,23-25,32,34H,14H2,1-4H3,(H,37,38)
C30H29ClN2O7565.0134599999992100
5450309

2 of 3 defined stereocentres - 2/3 defined
InChI=1/C30H29ClN2O7/c1-16-27(30(35)40-20-5-3-2-4-6-20)28(21-13-25-26(39-15-38-25)14-23(21)33(36)37)29-22(32-16)11-18(12-24(29)34)17-7-9-19(31)10-8-17/h7-10,13-14,18,20,27-28H,2-6,11-12,15H2,1H3/t18-,27?,28-/m0/s1
C30H29ClN2O7565.01352100
5450310

2 of 3 defined stereocentres - 2/3 defined
InChI=1/C30H29ClN2O7/c1-16-27(30(35)40-20-5-3-2-4-6-20)28(21-13-25-26(39-15-38-25)14-23(21)33(36)37)29-22(32-16)11-18(12-24(29)34)17-7-9-19(31)10-8-17/h7-10,13-14,18,20,27-28H,2-6,11-12,15H2,1H3/t18-,27?,28+/m0/s1
C30H29ClN2O7565.01352100
5450311

2 of 3 defined stereocentres - 2/3 defined
InChI=1/C30H29ClN2O7/c1-16-27(30(35)40-20-5-3-2-4-6-20)28(21-13-25-26(39-15-38-25)14-23(21)33(36)37)29-22(32-16)11-18(12-24(29)34)17-7-9-19(31)10-8-17/h7-10,13-14,18,20,27-28H,2-6,11-12,15H2,1H3/t18-,27?,28+/m1/s1
C30H29ClN2O7565.01352100
5450312

2 of 3 defined stereocentres - 2/3 defined
InChI=1/C30H29ClN2O7/c1-16-27(30(35)40-20-5-3-2-4-6-20)28(21-13-25-26(39-15-38-25)14-23(21)33(36)37)29-22(32-16)11-18(12-24(29)34)17-7-9-19(31)10-8-17/h7-10,13-14,18,20,27-28H,2-6,11-12,15H2,1H3/t18-,27?,28-/m1/s1
C30H29ClN2O7565.01352100
21420912

Charge

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C30H29N2O3.ClHO4/c33-29(26-15-10-16-27(21-26)32(34)35)30(18-8-3-9-19-30)31-20-17-25(23-11-4-1-5-12-23)22-28(31)24-13-6-2-7-14-24;2-1(3,4)5/h1-2,4-7,10-17,20-22,29,33H,3,8-9,18-19H2;(H,2,3,4,5)/q+1;/p-1
C30H29ClN2O7565.01352200
64876561

Double-bond stereo
InChI=1/C30H29ClN2O7/c1-4-13-39-24-12-8-21(16-27(24)38-3)17-33-29(35)23(28(34)32-30(33)36)14-20-7-11-25(26(15-20)37-2)40-18-19-5-9-22(31)10-6-19/h5-12,14-16H,4,13,17-18H2,1-3H3,(H,32,34,36)/b23-14-
C30H29ClN2O7565.01352200
68787297

Double-bond stereo
InChI=1/C30H29ClN2O7/c1-5-38-21-10-11-25(39-6-2)24(16-21)33-29(35)22(28(34)32-30(33)36)13-20-14-23(31)27(26(15-20)37-4)40-17-19-9-7-8-18(3)12-19/h7-16H,5-6,17H2,1-4H3,(H,32,34,36)/b22-13+
C30H29ClN2O7565.01352100
117923879

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C30H29ClN2O7/c1-3-40-30(38)32-12-10-21(11-13-32)33-25(20-15-22(31)27(35)23(16-20)39-2)24(28(36)29(33)37)26(34)19-9-8-17-6-4-5-7-18(17)14-19/h4-9,14-16,21,25,35-36H,3,10-13H2,1-2H3
C30H29ClN2O7565.01351100
122013831

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C30H29ClN2O7/c1-19(34)39-25-11-9-21(10-12-25)15-27(32-29(36)23-6-4-8-26(17-23)40-20(2)35)30(37)33-13-14-38-28(18-33)22-5-3-7-24(31)16-22/h3-12,16-17,27-28H,13-15,18H2,1-2H3,(H,32,36)
C30H29ClN2O7565.01351100
122014006

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C30H29ClN2O7/c1-19(34)39-25-12-6-21(7-13-25)16-27(32-29(36)23-4-3-5-26(17-23)40-20(2)35)30(37)33-14-15-38-28(18-33)22-8-10-24(31)11-9-22/h3-13,17,27-28H,14-16,18H2,1-2H3,(H,32,36)
C30H29ClN2O7565.01351100
122299529

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C30H29ClN2O7/c1-19(34)39-25-10-6-21(7-11-25)16-27(32-29(36)22-8-12-26(13-9-22)40-20(2)35)30(37)33-14-15-38-28(18-33)23-4-3-5-24(31)17-23/h3-13,17,27-28H,14-16,18H2,1-2H3,(H,32,36)
C30H29ClN2O7565.01351100
122299735

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C30H29ClN2O7/c1-19(34)39-25-11-3-21(4-12-25)17-27(32-29(36)23-7-13-26(14-8-23)40-20(2)35)30(37)33-15-16-38-28(18-33)22-5-9-24(31)10-6-22/h3-14,27-28H,15-18H2,1-2H3,(H,32,36)
C30H29ClN2O7565.01351100
125493916
InChI=1/C30H29ClN2O7/c1-37-16-17-40-30(36)20-9-11-21(12-10-20)32-27-26(22-6-4-5-7-23(22)31)28(34)33(29(27)35)15-14-19-8-13-24(38-2)25(18-19)39-3/h4-13,18,32H,14-17H2,1-3H3
C30H29ClN2O7565.01351100
125511115
InChI=1/C30H29ClN2O7/c1-17(2)40-30(36)19-11-9-18(10-12-19)16-33-28(34)26(20-7-6-8-21(13-20)37-3)27(29(33)35)32-23-15-24(38-4)22(31)14-25(23)39-5/h6-15,17,32H,16H2,1-5H3
C30H29ClN2O7565.01351100
24814264

Charge

0 of 3 defined stereocentres - 0/3 defined
InChI=1/C30H31ClN2O7/c1-30(2,3)16-33-23-12-11-18(31)13-21(23)27(20-10-6-8-17-7-4-5-9-19(17)20)40-24(28(33)37)15-25(34)32-22(29(38)39)14-26(35)36/h4-13,22,24,27H,14-16H2,1-3H3,(H,32,34)(H,35,36)(H,38,39)/p-2
C30H29ClN2O7565.01461100
1234

Advertisement